 higher recurrent varicosity score
(SMD, e0.33; 95% CI, e0.50 to e0.17; 1 study102). Outcomes are presented in Supplementary Table V (online
only).
Adverse events.
Minor AEs. Compared with RFA, HL/S was signiÔ¨Åcantly
associated with increased risk of minor AEs (RR, 1.70; 95%
CI, 